SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024436
Filing Date
2022-11-10
Accepted
2022-11-10 16:03:55
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q revb-20220930.htm   iXBRL 10-Q 2567088
2 EX-31.1 revb-ex31_1.htm EX-31.1 43537
3 EX-31.2 revb-ex31_2.htm EX-31.2 43597
4 EX-32.1 revb-ex32_1.htm EX-32.1 15656
5 EX-32.2 revb-ex32_2.htm EX-32.2 16575
  Complete submission text file 0000950170-22-024436.txt   8392144

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20220930.xsd EX-101.SCH 55567
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20220930_def.xml EX-101.DEF 272913
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20220930_lab.xml EX-101.LAB 428255
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20220930_pre.xml EX-101.PRE 360878
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT revb-20220930_cal.xml EX-101.CAL 30526
57 EXTRACTED XBRL INSTANCE DOCUMENT revb-20220930_htm.xml XML 1289739
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39603 | Film No.: 221376970
SIC: 2834 Pharmaceutical Preparations